Skip to main content
. 2017 Jun 16;8(57):96945–96957. doi: 10.18632/oncotarget.18547

Figure 5. Correlation of CALR and PDIA3 in NSCLC.

Figure 5

(A) Co-expression of CALR and PDIA3 in patients with NSCLC detected by immunohistochemistry. Scale bar = 50 μm. (B) Interaction of CALR-PDIA3 in two lung cancer cell lines tested by co-IP assay. (C) Co-localization of CALR and PDIA3 in A549 and H460 cell lines visualized under a confocal florescence microscopy. Scale bar = 10 μm.